Your browser doesn't support javascript.
loading
Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome.
Braud, Véronique M; Biton, Jérôme; Becht, Etienne; Knockaert, Samantha; Mansuet-Lupo, Audrey; Cosson, Estelle; Damotte, Diane; Alifano, Marco; Validire, Pierre; Anjuère, Fabienne; Cremer, Isabelle; Girard, Nicolas; Gossot, Dominique; Seguin-Givelet, Agathe; Dieu-Nosjean, Marie-Caroline; Germain, Claire.
Afiliação
  • Braud VM; Université Côte d'Azur, CNRS UMR7275, Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), Valbonne, France.
  • Biton J; Laboratory "Immune Microenvironment and Tumors", Department "Cancer, Immunology, Immunotherapy", INSERM UMRS 1138, Cordeliers Research Center, Paris, France.
  • Becht E; University Pierre and Marie Curie/Paris VI, Paris, France.
  • Knockaert S; University Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France.
  • Mansuet-Lupo A; Laboratory "Immune Microenvironment and Tumors", Department "Cancer, Immunology, Immunotherapy", INSERM UMRS 1138, Cordeliers Research Center, Paris, France.
  • Cosson E; University Pierre and Marie Curie/Paris VI, Paris, France.
  • Damotte D; University Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France.
  • Alifano M; Laboratory "Immune Microenvironment and Tumors", Department "Cancer, Immunology, Immunotherapy", INSERM UMRS 1138, Cordeliers Research Center, Paris, France.
  • Validire P; University Pierre and Marie Curie/Paris VI, Paris, France.
  • Anjuère F; University Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France.
  • Cremer I; Laboratory "Immune Microenvironment and Tumors", Department "Cancer, Immunology, Immunotherapy", INSERM UMRS 1138, Cordeliers Research Center, Paris, France.
  • Girard N; University Pierre and Marie Curie/Paris VI, Paris, France.
  • Gossot D; University Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France.
  • Seguin-Givelet A; Department of Pathology, Hôpitaux Universitaires Paris Centre, AP-HP, Paris, France.
  • Dieu-Nosjean MC; Université Côte d'Azur, CNRS UMR7275, Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), Valbonne, France.
  • Germain C; Laboratory "Immune Microenvironment and Tumors", Department "Cancer, Immunology, Immunotherapy", INSERM UMRS 1138, Cordeliers Research Center, Paris, France.
Oncoimmunology ; 7(5): e1423184, 2018.
Article em En | MEDLINE | ID: mdl-29721382
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França